R-4733
N/A
Report date: 2024/07/05 11:15:13
NME
Base Information
Drug NameR-4733
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[105]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNational Cancer InstituteF. Hoffmann-La Roche Ltd
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesF. Hoffmann-La Roche LtdNational Cancer Institute
Active IndicationsN/A
Inactive Indications +[105]
Other Information
ATC CodeN/A
Related LinksN/A